Printer Friendly

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014.

NEW YORK, June 2, 2014 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue: Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014

http://www.reportlinker.com/p02133116/Aneurysmal-Subarachnoid-Hemorrhage-SAH-Global-Clinical-Trials-Review-H1-2014.html

Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, "Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014" provides data on the Aneurysmal Subarachnoid Hemorrhage (SAH) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Aneurysmal Subarachnoid Hemorrhage (SAH). It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Aneurysmal Subarachnoid Hemorrhage (SAH). This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner

- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

- Obtain discontinued trial listing for trials across the globe

- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 5

Introduction 6

Aneurysmal Subarachnoid Hemorrhage (SAH) 6

Report Guidance 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials 18

Clinical Trials by Phase in E7 Countries 19

Clinical Trials in E7 Countries by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Clinical Trials by End Point Status 24

Unaccomplished Trials of Aneurysmal Subarachnoid Hemorrhage (SAH) 25

Subjects Recruited Over a Period of Time 26

Clinical Trials by Sponsor Type 27

Prominent Sponsors 28

Top Companies Participating in Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials 29

Prominent Drugs 30

Clinical Trial Profiles 31

Clinical Trial Overview of Top Companies 31

Actelion Ltd 31

Clinical Trial Overview of Actelion Ltd 31

Edge Therapeutics, Inc. 32

Clinical Trial Overview of Edge Therapeutics, Inc. 32

Clinical Trial Overview of Top Institutes / Government 33

Vanderbilt University 33

Clinical Trial Overview of Vanderbilt University 33

Chinese University of Hong Kong 34

Clinical Trial Overview of Chinese University of Hong Kong 34

Kuopio University Hospital 35

Clinical Trial Overview of Kuopio University Hospital 35

University of Cambridge 36

Clinical Trial Overview of University of Cambridge 36

Charite - Universitatsmedizin Berlin 37

Clinical Trial Overview of Charite - Universitatsmedizin Berlin 37

Utrecht University 38

Clinical Trial Overview of Utrecht University 38

Oslo University Hospital 39

Clinical Trial Overview of Oslo University Hospital 39

Rigshospitalet 40

Clinical Trial Overview of Rigshospitalet 40

University of Miami 41

Clinical Trial Overview of University of Miami 41

University of Calgary 42

Clinical Trial Overview of University of Calgary 42

Five Key Clinical Profiles 43

Appendix 73

Abbreviations 73

Definitions 73

Research Methodology 74

Secondary Research 74

About GlobalData 75

Contact Us 75

Disclaimer 75

Source 75

List of Tables Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Region, 2014* 7Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries, 2014* 12Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014* 13Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 14Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Phase, 2014* 21Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Terminated Clinical Trials, 2014* 25Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 27Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Actelion Ltd, 2014* 31Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Edge Therapeutics, Inc., 2014* 32Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt University, 2014* 33Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2014* 34Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Kuopio University Hospital, 2014* 35Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Cambridge, 2014* 36Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Charite - Universitatsmedizin Berlin, 2014* 37Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Utrecht University, 2014* 38Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Oslo University Hospital, 2014* 39Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by Rigshospitalet, 2014* 40Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Miami, 2014* 41Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Calgary, 2014* 42 List of Figures Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Region (%), 2014* 7Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2014* 14Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, G7 Countries (%), 2014* 15Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17Proportion of Aneurysmal Subarachnoid Hemorrhage (SAH) to Central Nervous System Clinical Trials, E7 Countries (%), 2014* 18Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 26Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 27Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 28Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 29Aneurysmal Subarachnoid Hemorrhage (SAH) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 30GlobalData Methodology 74

Companies Mentioned

To order this report: Aneurysmal Subarachnoid Hemorrhage (SAH) Global Clinical Trials Review, H1, 2014 http://www.reportlinker.com/p02133116/Aneurysmal-Subarachnoid-Hemorrhage-SAH-Global-Clinical-Trials-Review-H1-2014.html__________________________

Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

SOURCE Reportlinker
COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 2, 2014
Words:1845
Previous Article:Acute Ischemic Stroke Global Clinical Trials Review, H1, 2014.
Next Article:Asperger Syndrome Global Clinical Trials Review, H1, 2014.
Topics:

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters